2015
Plaque Psoriasis
Sponsor: Therapeutics, Inc.
A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis
Phase: Phase 3
Start Date: January 2015
End Date: February 2017
Actinic Keratosis
Sponsor: Actavis Inc.
A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis
Phase: Phase 3
Start Date: February 2015
End Date: September 2015
Actinic Keratosis
Sponsor: Actavis Inc.
Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis
Phase: Phase 3
Start Date: February 2015
End Date: October 2015
Hyperhidrosis
Sponsor: Brickell Biotech, Inc.
A Safety and Efficacy Study of BBI-4000 in Subjects With Axillary Hyperhidrosis
Phase: Phase 2
Start Date: February 2015
End Date: December 2015
Nodulocystic Acne
Sponsor: Elorac, Inc.
Finasteride Treatment of Male Subjects with Severe Nodulocystic Acne
Phase: Phase 2
Start Date: July 2015
End Date: July 2017
Hyperhidrosis
Sponsor: Dermira, Inc.
Study of DRM04 in Axillary Hyperhydrosis
Phase: Phase 3
Start Date: July 2015
End Date: March 2016
Hyperhidrosis
Sponsor: Dermira, Inc.
Long-term Safety Study of DRM04 in Subjects With Primary Axillary Hyperhidrosis
Phase: Phase 3
Start Date: August 2015
End Date: December 2016
Acne Vulgaris
Sponsor: Cassiopea SpA
A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (25)
Phase: Phase 3
Start Date: November 2015
End Date: August 2017